Naloxone Aguettant (Anhydrous Naloxone Hydrochloride)

Naloxone, the active ingredient in Naloxone Aguettant, is an opioid antagonist presented as a sterile solution for intramuscular, intravenous, or subcutaneous use. It rapidly reverses opioid‑induced respiratory depression and other life‑threatening effects of opioid overdose in emergency settings.

GNH USA supplies Naloxone Aguettant as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable delivery across global markets.

Naloxone is an opioid antagonist used in the management of opioid overdose and related respiratory depression. - Opioid overdose: rapidly restores normal breathing and consciousness. - Opioid‑induced respiratory depression: reverses respiratory suppression caused by opioid analgesics. - Acute opioid toxicity: counteracts life‑threatening effects of opioid toxicity in emergency care.

Naloxone may cause a range of adverse reactions, most of which are related to its rapid reversal of opioid effects.

Common Side Effects: - Nausea: mild to moderate nausea may occur. - Vomiting: occasional vomiting after administration. - Sweating: increased perspiration. - Agitation: transient restlessness or anxiety.

Serious or Rare Side Effects: - Cardiac arrhythmia: rare irregular heart rhythms. - Seizure: infrequent seizures in susceptible individuals. - Pulmonary edema: rare fluid accumulation in the lungs. - Hypertension: sudden high blood pressure.

Naloxone should be used with careful clinical assessment and monitoring. - Assess patient: confirm opioid overdose before administration. - Monitor vital signs: observe respiratory rate, heart rate, and blood pressure after dosing. - Re‑dose if needed: be prepared to repeat naloxone if opioid effect persists. - Consider underlying conditions: patients with cardiovascular disease may experience tachycardia. - Avoid in hypersensitivity: do not use if known allergy to naloxone or formulation components. - Store at ambient temperature: keep below 25°C, protect from moisture and light, retain in original packaging.

Naloxone may interact with other medications that affect the central nervous system or cardiovascular function.

Major Interactions (Avoid): - Opioid agonists: concurrent high‑dose opioids may diminish naloxone effect, requiring higher doses. - Monoamine oxidase inhibitors (MAOIs): may increase risk of hypertensive crisis when combined with naloxone.

Moderate Interactions (Monitor Closely): - Benzodiazepines: may mask withdrawal symptoms after naloxone reversal. - Tricyclic antidepressants: potential for additive cardiovascular effects. - Alcohol: may exacerbate central nervous system stimulation.